Biomerics, a mid-market medical device contract manufacturer, has announced it is expanding its manufacturing footprint in Athens, Texas. This announcement follows on from the company's recent announcement of an expansion in Costa Rica.
Founded in 1993, Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in the attractive PTA, endourology, and endoscopy markets.
The expansion is in support of active transfer programmes with strategic customers and major OEMs. The plans total 24,000 sqft of expanded space, including professional office space, engineering labs, quality inspection labs, 10,000 sqft ISO Class 8 cleanroom, and machining centre.
Biomerics FMI currently employs 420 people at its 80,000 sqft five facility campus, a center of excellence in extrusion, injection moulding, medical balloon forming, advanced shaft reflow, coating, catheter assembly, packaging, and sterilisation.
"We are excited to expand our footprint in Athens, Texas," said Travis Sessions, Biomerics CEO. "Biomerics FMI has storied history in this community and we look forward to continuing this legacy."
"We are excited about the value that this expansion brings to our customers. The established cross-functional teams at BFMI are well prepared to execute new development and tech transfer programs to fill the cleanroom space," explained Chris Richardson, Biomerics Director of Sales and Marketing. "The favourable business climate in Texas combined with a vertically integrated development and manufacturing positions Biomerics FMI as an ideal US contract manufacturing partner."
Construction is expected to be completed by Q4 2021 and will be celebrated with an open house.
